Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Addex Therapeutics Ltd
  6. News
  7. Summary
    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD

(ADXN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Addex Therapeutics : HC Wainwright Initiates Addex Therapeutics at Buy Rating With $28 Price Target

04/21/2021 | 09:26am EST


ę MT Newswires 2021
All news about ADDEX THERAPEUTICS LTD
11/18Addex to Present at the Virtual German Equity Forum
AQ
11/15ADDEX THERAPEUTICS : Setting Up Global Expansion of Phase 2 Clinical Evaluation in Epileps..
PU
11/15Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
AQ
11/15Addex to Present at the H.C. Wainwright 7th Annual Israel Virtual Conference
AQ
11/04INDEX TO UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Form 6-K
PU
11/04Addex Therapeutics Ltd Reports Earnings Results for the Third Quarter and Nine Months E..
CI
11/04Addex Reports Q3 2021 Financial Results and Provides Corporate Update
AQ
11/01Addex Therapeutics to Release Q3 2021 Financial Results and Host Conference Call on Nov..
GL
10/06Addex to Present at the Investors' Day hosted by Voxia Communication
DJ
10/06ADDEX THERAPEUTICS : Addex to Present at the Investors' Day hosted by Voxia Communication
GL
More news
Analyst Recommendations on ADDEX THERAPEUTICS LTD
More recommendations
Financials
Sales 2021 2,35 M 2,55 M 2,55 M
Net income 2021 -16,5 M -17,9 M -17,9 M
Net Debt 2021 5,28 M 5,72 M 5,72 M
P/E ratio 2021 -2,31x
Yield 2021 -
Capitalization 37,9 M 41,1 M 41,1 M
EV / Sales 2021 18,4x
EV / Sales 2022 33,1x
Nbr of Employees 27
Free-Float 65,2%
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 1,11 CHF
Average target price 25,72 CHF
Spread / Average Target 2 217%
EPS Revisions
Managers and Directors
Timothy Dyer Chief Executive Officer & Director
LÚnaic TeyssÚdou Head-Finance
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Sector and Competitors
1st jan.Capi. (M$)
ADDEX THERAPEUTICS LTD-44.22%41
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431